Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

hennig arzneimittel gmbh & co kg, florsheim/main, germany liebigstr. 1-2, 65439, florsheim/main - cinnarizine; dimenhydrinate - tab (ΔΙΣΚΙΟ) - (20+40)mg/tab - cinnarizine 20mg; dimenhydrinate 40mg - cinnarizine, combinations

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

hennig arzneimittel gmbh & co kg (0000008448) liebigstr. 1-2, florsheim am main, 65439 - cinnarizine; dimenhydrinate - tablets - cinnarizine (0000298577) 20mg; dimenhydrinate (0000523875) 40mg - cinnarizine, combinations

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - Ανοσοκατασταλτικά - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

ge healthcare buchler gmbh & co kg (0000003641) gieselweg 1, braunschweig, 38110 - sodium iodide (131 i) - capsule,hard - 37mbq to 5.55gbq - sodium iodide (131 i) (0007790263) 222gbq

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

colep laupheim gmbh & co kg (0000009764) fockestrasse 12, laupheim, de-88471 - menthol racemic; eucalyptus oil; methyl salicylate; turpentine oil - cream - menthol racemic (8000002894) 5,91% w/w; eucalyptus oil (0008000484) 1,97% w/w; methyl salicylate (0000119368) 12,8% w/w; turpentine oil (0008006642) 1,47% w/w

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - upadacitinib - Αρθρίτιδα, ρευματοειδή - Ανοσοκατασταλτικά - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

ge healthcare buchler gmbh & co kg (0000003641) gieselweg 1, braunschweig, 38110 - iobenguane (131 i) - solution for injection - 9.25-18.5mbq/ml - iobenguane (131 i) (8000003407) 9,25mbq

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

cheplapharm arzneimittel gmbh, greifswald, germany ziegelhof 24, 17489 greifswald - carvedilol - tab (ΔΙΣΚΙΟ) - 25mg/tab - carvedilol 25mg - carvedilol

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

cheplapharm arzneimittel gmbh, greifswald, germany ziegelhof 24, 17489 greifswald - carvedilol - tab (ΔΙΣΚΙΟ) - 6,25mg/tab - carvedilol 6,25mg - carvedilol

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

cheplapharm arzneimittel gmbh, greifswald, germany ziegelhof 24, 17489 greifswald - carvedilol - tab (ΔΙΣΚΙΟ) - 12,5mg/tab - carvedilol 12,5mg - carvedilol